Articles Mentioning Healthcare Stocks

Results 1 - 10 of 481 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare

Investing | March 19, 2015

This Exciting Biotech Isn't Built to Last

Acadia Pharmaceuticals' Parkinson's disease drug was guaranteed a speedy review and the attention of top FDA officials. So why did this company's stock recently tank so rapidly? There's a cautionary tale here for all biotech investors.

Investing | March 09, 2015

Why AbbVie Inc.'s $21 Billion Deal Had To Happen

AbbVie Inc has agreed to pay $21 billion to acquire Pharmacyclics, Inc.

Investing | February 16, 2015

Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?

Pfizer recently acquired Hospira for $17 billion, but it has plenty of fuel left to go after more deals to boost its pipeline and shareholder value.

Investing | February 14, 2015

2 Small Biotech Stocks Dreaming Big in Hepatitis C

Exciting but speculative -- Industry Focus examines two companies making strides in the treatment of hepatitis C.

Investing | February 01, 2015

The Top Healthcare Stock to Buy in February

3 Motley Fool contributors share their top picks for February.

Investing | January 31, 2015

Big Pharma: An Up-Close Look at One Key Player

Industry Focus zooms in on restructuring, new drugs, and possible threats for pharma giant Novartis.

Investing | January 31, 2015

Can You Guess What Legal Drug Outsells the NFL?

The NFL is unquestionably one of the most successful American businesses of all-time. Surprisingly, though, the NFL's 2013 revenues were no match for this single legal drug.

Investing | January 20, 2015

Can AbbVie Inc. Overcome Humira’s Looming Patent Expiration?

AbbVie's most important product, Humira, will lose patent exclusivity in the U.S. in 2016. Should investors fear this upcoming event?

Investing | January 11, 2015

Should AbbVie Inc. Or Gilead Sciences Buy These Tiny Biotech Stocks?

AbbVie Inc and Gilead Sciences may want to consider Achillion Pharmaceuticals' and Regulus Therapeutics' intriguing hepatitis C drugs.

Investing | January 11, 2015

5 Predictions for Biotechnology Stocks in 2015

Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.

Results 1 - 10 of 481 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare